FDA "cosmeceutical" regulatory class with premarket approval advocated by J&J researcher.
This article was originally published in The Rose Sheet
FDA "COSMECEUTICAL" REGULATORY SCHEME WITH PREMARKET APPROVAL ADVOCATED by Johnson & Johnson Consumer Products Worldwide VP-Research & Development Geert Cauwenbergh at a 1996 HBA Global Expo symposium on the future of skin care in New York City June 3. Predicting that FDA will address the regulatory issue of "cosmeceuticals" in the next five years, Cauwenbergh suggested that three "key" requirements be established as part of a cosmeceutical approval process.
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review